SCHEMBL28058700

SCHEMBL28058700

CSc1cccc(-c2cn(C3CC3)cn2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.47
DRD4 P21917 2/20 0.47
DRD3 P35462 2/20 0.47
IDO1 P14902 1/20 0.41
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4D Q08499 2/20 0.39
PDE4C Q08493 1/20 0.39
KDM2B Q8NHM5 1/20 0.39
CNR1 P21554 3/20 0.38
LRRK2 Q5S007 1/20 0.37
BACE1 P56817 2/20 0.37
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
PDE10A Q9Y233 1/20 0.35
TGFBR1 P36897 1/20 0.34
MAPK13 O15264 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17083894 0.72 DRD2 (0.60) DRD2DRD4DRD3KDM2BCNR1
Hydrochloric Acid SCHEMBL16986263 0.71 DRD2 (0.59) DRD2DRD4DRD3KDM2BCNR1
Hydrochloric Acid SCHEMBL16986261 0.71 DRD2 (0.59) DRD2DRD4DRD3KDM2BCNR1
SCHEMBL16986272 0.70 DRD2 (0.58) DRD2DRD4DRD3KDM2BCNR1
SCHEMBL16986269 0.70 DRD2 (0.58) DRD2DRD4DRD3KDM2BCNR1
SCHEMBL17083892 0.69 MAP4K3 (0.48) DRD2DRD4DRD3IDO1KDM2B
SCHEMBL15830635 0.69 DRD2 (0.50) DRD2DRD4DRD3KDM2BCNR1
SCHEMBL1581846 0.69 DRD2 (0.60) DRD2DRD4DRD3KDM2BMAP3K7
SCHEMBL27940238 0.69 IDO1 (0.38) DRD2DRD4DRD3IDO1PDE4A
Hydrochloric Acid SCHEMBL16986237 0.69 MAP4K3 (0.47) DRD2DRD4DRD3IDO1KDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103443100-B The 6-Imidazopyrazines of the replacement of MPS-1 and TKK inhibitor is used as in the treatment of hyperproliferative disorders BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-03-23 CN disclosed